Bioengineering & Translational Medicine

Wiley

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Bioengineering & Translational Medicine is an open-access journal published by Wiley in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,180 USD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
2380-6761
Country
United States
Languages
english
Access
Open access
Declared publication charge
3,180 USD
Articles in DOAJ
701
Declared review time
12 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2016-11-08
Indexing
DOAJ
APC
3,180 USD
Declared review time (DOAJ)
12 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

701

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

12weeks

Works in OpenAlex

953

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

71

i10-index

483

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2016-11-08
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
87%
ORCID iDs in current deposits
85%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Bioengineering and translational medicineBioeng Transl Med
Source type
journal
NLM unique ID (PubMed)
101689146
Classification6

Subjects (DOAJ)

Technology: Chemical technology: Chemical engineeringTechnology: Chemical technology: BiotechnologyMedicine: Therapeutics. Pharmacology

LCC codes

TP155-156TP248.13-248.65RM1-950

Subject areas

  • 3D Printing in Biomedical Research
  • 3D Printing in Biomedical Research
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • Tissue Engineering and Regenerative Medicine
  • Tissue Engineering and Regenerative Medicine
Show all subjects (50)
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Electrospun Nanofibers in Biomedical Applications
  • Electrospun Nanofibers in Biomedical Applications
  • Wound Healing and Treatments
  • Mesenchymal stem cell research
  • Mesenchymal stem cell research
  • Wound Healing and Treatments
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Extracellular vesicles in disease
  • Extracellular vesicles in disease
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Biomedical Ethics and Regulation
  • CAR-T cell therapy research
  • Biomedical Ethics and Regulation
  • CAR-T cell therapy research
  • Cellular Mechanics and Interactions
  • Cellular Mechanics and Interactions
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Bone Tissue Engineering Materials
  • Nerve injury and regeneration
  • Nerve injury and regeneration
  • Bone Tissue Engineering Materials
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • Pluripotent Stem Cells Research
  • Pluripotent Stem Cells Research
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Immune cells in cancer
  • Graphene and Nanomaterials Applications
  • Immune cells in cancer
  • Graphene and Nanomaterials Applications
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Pancreatic function and diabetes
  • Pancreatic function and diabetes

Keywords (DOAJ)

  • drug delivery
  • tissue engineering
  • synthetic biology
  • biosensors
  • biomolecular engineering
  • immunotherapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: